1 Market Overview

1.1 Product Overview and Scope of Artificial Intelligence (AI) in Cancer

1.2 Classification of Artificial Intelligence (AI) in Cancer by Type

1.2.1 Overview: Global Artificial Intelligence (AI) in Cancer Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type in 2020

1.2.3 Surgery

1.2.4 Radiotherapy

1.2.5 Chemotherapy

1.2.6 Immunotherapy

1.2.7 Phototherapy

1.2.8 Gene Therapy

1.2.9 Sonodynamic Therapy

1.3 Global Artificial Intelligence (AI) in Cancer Market by Application

1.3.1 Overview: Global Artificial Intelligence (AI) in Cancer Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Diagnosis

1.3.3 Therapy

1.3.4 Prognosis

1.3.5 Health Management

1.3.6 Research

1.4 Global Artificial Intelligence (AI) in Cancer Market Size & Forecast

1.5 Global Artificial Intelligence (AI) in Cancer Market Size and Forecast by Region

1.5.1 Global Artificial Intelligence (AI) in Cancer Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Artificial Intelligence (AI) in Cancer Market Size by Region, (2016-2021)

1.5.3 North America Artificial Intelligence (AI) in Cancer Market Size and Prospect (2016-2026)

1.5.4 Europe Artificial Intelligence (AI) in Cancer Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size and Prospect (2016-2026)

1.5.6 South America Artificial Intelligence (AI) in Cancer Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Artificial Intelligence (AI) in Cancer Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Artificial Intelligence (AI) in Cancer Market Drivers

1.6.2 Artificial Intelligence (AI) in Cancer Market Restraints

1.6.3 Artificial Intelligence (AI) in Cancer Trends Analysis

2 Company Profiles

2.1 IBM

2.1.1 IBM Details

2.1.2 IBM Major Business

2.1.3 IBM Artificial Intelligence (AI) in Cancer Product and Solutions

2.1.4 IBM Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 IBM Recent Developments and Future Plans

2.2 Microsoft

2.2.1 Microsoft Details

2.2.2 Microsoft Major Business

2.2.3 Microsoft Artificial Intelligence (AI) in Cancer Product and Solutions

2.2.4 Microsoft Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Microsoft Recent Developments and Future Plans

2.3 NVIDIA

2.3.1 NVIDIA Details

2.3.2 NVIDIA Major Business

2.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Product and Solutions

2.3.4 NVIDIA Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 NVIDIA Recent Developments and Future Plans

2.4 Intel

2.4.1 Intel Details

2.4.2 Intel Major Business

2.4.3 Intel Artificial Intelligence (AI) in Cancer Product and Solutions

2.4.4 Intel Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Intel Recent Developments and Future Plans

2.5 GE Healthcare

2.5.1 GE Healthcare Details

2.5.2 GE Healthcare Major Business

2.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Product and Solutions

2.5.4 GE Healthcare Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 GE Healthcare Recent Developments and Future Plans

2.6 Johnson & Johnson

2.6.1 Johnson & Johnson Details

2.6.2 Johnson & Johnson Major Business

2.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Product and Solutions

2.6.4 Johnson & Johnson Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Johnson & Johnson Recent Developments and Future Plans

2.7 Cancer Center.ai

2.7.1 Cancer Center.ai Details

2.7.2 Cancer Center.ai Major Business

2.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Product and Solutions

2.7.4 Cancer Center.ai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Cancer Center.ai Recent Developments and Future Plans

2.8 Digital Reasoning

2.8.1 Digital Reasoning Details

2.8.2 Digital Reasoning Major Business

2.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Product and Solutions

2.8.4 Digital Reasoning Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Digital Reasoning Recent Developments and Future Plans

2.9 Varian Medical Systems

2.9.1 Varian Medical Systems Details

2.9.2 Varian Medical Systems Major Business

2.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Solutions

2.9.4 Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Varian Medical Systems Recent Developments and Future Plans

2.10 Niramai

2.10.1 Niramai Details

2.10.2 Niramai Major Business

2.10.3 Niramai Artificial Intelligence (AI) in Cancer Product and Solutions

2.10.4 Niramai Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Niramai Recent Developments and Future Plans

2.11 Densitas

2.11.1 Densitas Details

2.11.2 Densitas Major Business

2.11.3 Densitas Artificial Intelligence (AI) in Cancer Product and Solutions

2.11.4 Densitas Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Densitas Recent Developments and Future Plans

2.12 MammoScreen

2.12.1 MammoScreen Details

2.12.2 MammoScreen Major Business

2.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Product and Solutions

2.12.4 MammoScreen Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 MammoScreen Recent Developments and Future Plans

2.13 MVision AI

2.13.1 MVision AI Details

2.13.2 MVision AI Major Business

2.13.3 MVision AI Artificial Intelligence (AI) in Cancer Product and Solutions

2.13.4 MVision AI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 MVision AI Recent Developments and Future Plans

2.14 Volpara

2.14.1 Volpara Details

2.14.2 Volpara Major Business

2.14.3 Volpara Artificial Intelligence (AI) in Cancer Product and Solutions

2.14.4 Volpara Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Volpara Recent Developments and Future Plans

2.15 LungLifeAI

2.15.1 LungLifeAI Details

2.15.2 LungLifeAI Major Business

2.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Product and Solutions

2.15.4 LungLifeAI Artificial Intelligence (AI) in Cancer Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 LungLifeAI Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Artificial Intelligence (AI) in Cancer Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Artificial Intelligence (AI) in Cancer Players Market Share

3.2.2 Top 10 Artificial Intelligence (AI) in Cancer Players Market Share

3.2.3 Market Competition Trend

3.3 Artificial Intelligence (AI) in Cancer Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Artificial Intelligence (AI) in Cancer Revenue and Market Share by Type (2016-2021)

4.2 Global Artificial Intelligence (AI) in Cancer Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2016-2021)

5.2 Artificial Intelligence (AI) in Cancer Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2026)

6.2 North America Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2026)

6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Country

6.3.1 North America Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2026)

6.3.2 United States Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

6.3.3 Canada Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

6.3.4 Mexico Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2026)

7.2 Europe Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2026)

7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Country

7.3.1 Europe Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2026)

7.3.2 Germany Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

7.3.3 France Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

7.3.5 Russia Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

7.3.6 Italy Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2026)

8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2026)

8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region

8.3.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Region (2016-2026)

8.3.2 China Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8.3.3 Japan Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8.3.4 South Korea Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8.3.5 India Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

8.3.7 Australia Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2026)

9.2 South America Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2026)

9.3 South America Artificial Intelligence (AI) in Cancer Market Size by Country

9.3.1 South America Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2026)

9.3.2 Brazil Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

9.3.3 Argentina Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2026)

10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2026)

10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country

10.3.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2026)

10.3.2 Turkey Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

10.3.4 UAE Artificial Intelligence (AI) in Cancer Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Artificial Intelligence (AI) in Cancer Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Artificial Intelligence (AI) in Cancer Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Artificial Intelligence (AI) in Cancer Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Artificial Intelligence (AI) in Cancer Revenue (USD Million) by Region (2016-2021)

Table 5. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2021-2026)

Table 6. IBM Corporate Information, Head Office, and Major Competitors

Table 7. IBM Major Business

Table 8. IBM Artificial Intelligence (AI) in Cancer Product and Solutions

Table 9. IBM Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Microsoft Corporate Information, Head Office, and Major Competitors

Table 11. Microsoft Major Business

Table 12. Microsoft Artificial Intelligence (AI) in Cancer Product and Solutions

Table 13. Microsoft Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. NVIDIA Corporate Information, Head Office, and Major Competitors

Table 15. NVIDIA Major Business

Table 16. NVIDIA Artificial Intelligence (AI) in Cancer Product and Solutions

Table 17. NVIDIA Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Intel Corporate Information, Head Office, and Major Competitors

Table 19. Intel Major Business

Table 20. Intel Artificial Intelligence (AI) in Cancer Product and Solutions

Table 21. Intel Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. GE Healthcare Corporate Information, Head Office, and Major Competitors

Table 23. GE Healthcare Major Business

Table 24. GE Healthcare Artificial Intelligence (AI) in Cancer Product and Solutions

Table 25. GE Healthcare Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Johnson & Johnson Corporate Information, Head Office, and Major Competitors

Table 27. Johnson & Johnson Major Business

Table 28. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product and Solutions

Table 29. Johnson & Johnson Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Cancer Center.ai Corporate Information, Head Office, and Major Competitors

Table 31. Cancer Center.ai Major Business

Table 32. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product and Solutions

Table 33. Cancer Center.ai Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Digital Reasoning Corporate Information, Head Office, and Major Competitors

Table 35. Digital Reasoning Major Business

Table 36. Digital Reasoning Artificial Intelligence (AI) in Cancer Product and Solutions

Table 37. Digital Reasoning Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Varian Medical Systems Corporate Information, Head Office, and Major Competitors

Table 39. Varian Medical Systems Major Business

Table 40. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product and Solutions

Table 41. Varian Medical Systems Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Niramai Corporate Information, Head Office, and Major Competitors

Table 43. Niramai Major Business

Table 44. Niramai Artificial Intelligence (AI) in Cancer Product and Solutions

Table 45. Niramai Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Densitas Corporate Information, Head Office, and Major Competitors

Table 47. Densitas Major Business

Table 48. Densitas Artificial Intelligence (AI) in Cancer Product and Solutions

Table 49. Densitas Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. MammoScreen Corporate Information, Head Office, and Major Competitors

Table 51. MammoScreen Major Business

Table 52. MammoScreen Artificial Intelligence (AI) in Cancer Product and Solutions

Table 53. MammoScreen Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. MVision AI Corporate Information, Head Office, and Major Competitors

Table 55. MVision AI Major Business

Table 56. MVision AI Artificial Intelligence (AI) in Cancer Product and Solutions

Table 57. MVision AI Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Volpara Corporate Information, Head Office, and Major Competitors

Table 59. Volpara Major Business

Table 60. Volpara Artificial Intelligence (AI) in Cancer Product and Solutions

Table 61. Volpara Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. LungLifeAI Corporate Information, Head Office, and Major Competitors

Table 63. LungLifeAI Major Business

Table 64. LungLifeAI Artificial Intelligence (AI) in Cancer Product and Solutions

Table 65. LungLifeAI Artificial Intelligence (AI) in Cancer Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Global Artificial Intelligence (AI) in Cancer Revenue (USD Million) by Players (2019-2021)

Table 67. Global Artificial Intelligence (AI) in Cancer Revenue Share by Players (2019-2021)

Table 68. Breakdown of Artificial Intelligence (AI) in Cancer by Company Type (Tier 1, Tier 2 and Tier 3)

Table 69. Artificial Intelligence (AI) in Cancer Players Head Office, Products and Services Provided

Table 70. Artificial Intelligence (AI) in Cancer Mergers & Acquisitions in the Past Five Years

Table 71. Artificial Intelligence (AI) in Cancer New Entrants and Expansion Plans

Table 72. Global Artificial Intelligence (AI) in Cancer Revenue (USD Million) by Type (2016-2021)

Table 73. Global Artificial Intelligence (AI) in Cancer Revenue Share by Type (2016-2021)

Table 74. Global Artificial Intelligence (AI) in Cancer Revenue Forecast by Type (2021-2026)

Table 75. Global Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021)

Table 76. Global Artificial Intelligence (AI) in Cancer Revenue Forecast by Application (2021-2026)

Table 77. North America Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2021) & (USD Million)

Table 78. North America Artificial Intelligence (AI) in Cancer Revenue by Type (2021-2026) & (USD Million)

Table 79. North America Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021) & (USD Million)

Table 80. North America Artificial Intelligence (AI) in Cancer Revenue by Application (2021-2026) & (USD Million)

Table 81. North America Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2021) & (USD Million)

Table 82. North America Artificial Intelligence (AI) in Cancer Revenue by Country (2021-2026) & (USD Million)

Table 83. Europe Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2021) & (USD Million)

Table 84. Europe Artificial Intelligence (AI) in Cancer Revenue by Type (2021-2026) & (USD Million)

Table 85. Europe Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021) & (USD Million)

Table 86. Europe Artificial Intelligence (AI) in Cancer Revenue by Application (2021-2026) & (USD Million)

Table 87. Europe Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2021) & (USD Million)

Table 88. Europe Artificial Intelligence (AI) in Cancer Revenue by Country (2021-2026) & (USD Million)

Table 89. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2021) & (USD Million)

Table 90. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Type (2021-2026) & (USD Million)

Table 91. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021) & (USD Million)

Table 92. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Application (2021-2026) & (USD Million)

Table 93. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Region (2016-2021) & (USD Million)

Table 94. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue by Region (2021-2026) & (USD Million)

Table 95. South America Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2021) & (USD Million)

Table 96. South America Artificial Intelligence (AI) in Cancer Revenue by Type (2021-2026) & (USD Million)

Table 97. South America Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021) & (USD Million)

Table 98. South America Artificial Intelligence (AI) in Cancer Revenue by Application (2021-2026) & (USD Million)

Table 99. South America Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2021) & (USD Million)

Table 100. South America Artificial Intelligence (AI) in Cancer Revenue by Country (2021-2026) & (USD Million)

Table 101. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Type (2016-2021) & (USD Million)

Table 102. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Type (2021-2026) & (USD Million)

Table 103. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Application (2016-2021) & (USD Million)

Table 104. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Application (2021-2026) & (USD Million)

Table 105. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Country (2016-2021) & (USD Million)

Table 106. Middle East & Africa Artificial Intelligence (AI) in Cancer Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Artificial Intelligence (AI) in Cancer Picture

Figure 2. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type in 2020

Figure 3. Surgery

Figure 4. Radiotherapy

Figure 5. Chemotherapy

Figure 6. Immunotherapy

Figure 7. Phototherapy

Figure 8. Gene Therapy

Figure 9. Sonodynamic Therapy

Figure 10. Artificial Intelligence (AI) in Cancer Revenue Market Share by Application in 2020

Figure 11. Diagnosis Picture

Figure 12. Therapy Picture

Figure 13. Prognosis Picture

Figure 14. Health Management Picture

Figure 15. Research Picture

Figure 16. Global Artificial Intelligence (AI) in Cancer Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 17. Global Artificial Intelligence (AI) in Cancer Revenue and Forecast (2016-2026) & (USD Million)

Figure 18. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2016-2026)

Figure 19. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Region in 2020

Figure 20. North America Artificial Intelligence (AI) in Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Europe Artificial Intelligence (AI) in Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. South America Artificial Intelligence (AI) in Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 24. Middle East and Africa Artificial Intelligence (AI) in Cancer Revenue (USD Million) and Growth Rate (2016-2026)

Figure 25. Artificial Intelligence (AI) in Cancer Market Drivers

Figure 26. Artificial Intelligence (AI) in Cancer Market Restraints

Figure 27. Artificial Intelligence (AI) in Cancer Market Trends

Figure 28. IBM Recent Developments and Future Plans

Figure 29. Microsoft Recent Developments and Future Plans

Figure 30. NVIDIA Recent Developments and Future Plans

Figure 31. Intel Recent Developments and Future Plans

Figure 32. GE Healthcare Recent Developments and Future Plans

Figure 33. Johnson & Johnson Recent Developments and Future Plans

Figure 34. Cancer Center.ai Recent Developments and Future Plans

Figure 35. Digital Reasoning Recent Developments and Future Plans

Figure 36. Varian Medical Systems Recent Developments and Future Plans

Figure 37. Niramai Recent Developments and Future Plans

Figure 38. Densitas Recent Developments and Future Plans

Figure 39. MammoScreen Recent Developments and Future Plans

Figure 40. MVision AI Recent Developments and Future Plans

Figure 41. Volpara Recent Developments and Future Plans

Figure 42. LungLifeAI Recent Developments and Future Plans

Figure 43. Global Artificial Intelligence (AI) in Cancer Revenue Share by Players in 2020

Figure 44. Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 45. Global Top 3 Players Artificial Intelligence (AI) in Cancer Revenue Market Share in 2020

Figure 46. Global Top 10 Players Artificial Intelligence (AI) in Cancer Revenue Market Share in 2020

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 48. Global Artificial Intelligence (AI) in Cancer Revenue Share by Type in 2020

Figure 49. Global Artificial Intelligence (AI) in Cancer Market Share Forecast by Type (2021-2026)

Figure 50. Global Artificial Intelligence (AI) in Cancer Revenue Share by Application in 2020

Figure 51. Global Artificial Intelligence (AI) in Cancer Market Share Forecast by Application (2021-2026)

Figure 52. North America Artificial Intelligence (AI) in Cancer Sales Market Share by Type (2016-2026)

Figure 53. North America Artificial Intelligence (AI) in Cancer Sales Market Share by Application (2016-2026)

Figure 54. North America Artificial Intelligence (AI) in Cancer Revenue Market Share by Country (2016-2026)

Figure 55. United States Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Canada Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Mexico Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Europe Artificial Intelligence (AI) in Cancer Sales Market Share by Type (2016-2026)

Figure 59. Europe Artificial Intelligence (AI) in Cancer Sales Market Share by Application (2016-2026)

Figure 60. Europe Artificial Intelligence (AI) in Cancer Revenue Market Share by Country (2016-2026)

Figure 61. Germany Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. France Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. United Kingdom Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Russia Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Italy Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Asia-Pacific Artificial Intelligence (AI) in Cancer Sales Market Share by Type (2016-2026)

Figure 67. Asia-Pacific Artificial Intelligence (AI) in Cancer Sales Market Share by Application (2016-2026)

Figure 68. Asia-Pacific Artificial Intelligence (AI) in Cancer Revenue Market Share by Region (2016-2026)

Figure 69. China Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Japan Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South Korea Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. India Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Southeast Asia Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Australia Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South America Artificial Intelligence (AI) in Cancer Sales Market Share by Type (2016-2026)

Figure 76. South America Artificial Intelligence (AI) in Cancer Sales Market Share by Application (2016-2026)

Figure 77. South America Artificial Intelligence (AI) in Cancer Revenue Market Share by Country (2016-2026)

Figure 78. Brazil Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Argentina Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Middle East and Africa Artificial Intelligence (AI) in Cancer Sales Market Share by Type (2016-2026)

Figure 81. Middle East and Africa Artificial Intelligence (AI) in Cancer Sales Market Share by Application (2016-2026)

Figure 82. Middle East and Africa Artificial Intelligence (AI) in Cancer Revenue Market Share by Country (2016-2026)

Figure 83. Turkey Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Saudi Arabia Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. UAE Artificial Intelligence (AI) in Cancer Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source